EFFECT OF CASSIA AURICULATA FLOWERS, LEVES AND SEEDS DOSE DEPENDENT STUDY IN STREPTOZOTOCIN - INDUCED DIABETIC RATS.

Main Article Content

Murugan P
Sakthivel V
Jawahar S

Keywords

blood glucose, plasma insulin, pancreas, Cassia auriculata

Abstract

Diabetes is a major health problem affecting major populations worldwide. Cassia auriculata L. (Ceasalpiniaceae) has been used traditionally as antidiabetic and has been proven scientifically to possess high antioxidant activity and anticancer properties. Cassia auriculata L. is a shrub that has attractive yellow flowers, commonly used for the treatment of skin disorders and body odour. It is a native plant present in different parts of India. Indigenous people use various parts of the plant for diabetes mellitus. Streptozotocin (STZ)-nicotinamide type 2 model shares a number of features with human type 2 diabetes and is characterized by moderate stable hyperglycemia, glucose intolerance, altered but significant glucose-stimulated insulin secretion, in vivo and in vitro. Oral administration of Cassia auriculta  flower extract (CFEt), leaf extract (CLEt) and seed extract (CSEt)  at 0.45 mg/kg body weight to diabetic rats for 45 days.  In the present study, we have investigated of Tanner’s cassia CFEt, CLEt and CSEt on glucose levels were assayed. Our results indicate that administration of CFEt, CLEt and CSEt to diabetic animals normalizes blood glucose and causes marked improvement of altered blood glucose and plasma insulin during diabetes. The CFEt administration showed more effective than CLEt, CSEt and glibenclamide.

Abstract 160 | pdf Downloads 105

References

1. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985; 240: 500-508.
2. Chatterjee MN, Shinde R. Text book of Medical Biochemistry, 5th ed. Jaypee Brothers, Medical Publishers (P) Ltd, New Delhi 2002: 317.
3. Duncan, BD (1957). Multiple range test for correlated and heteroscedastic means. Biometrics. 13, 359-364.
4. Hossain MZ, Shibib BA, Rahman R. Hypoglycemic effects of Coccinia indica: Inhibition of key gluconeogenic enzyme, glucose-6-phosphatase. Indian J Exp Biol 1992; 10: 418-420.
5. Hu X, Sato J, Oshida Y, Xu M, Bajotto G, Sato Y. Effect of Gosha-jinkigan (Chinese herbal medicine): Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2003; 59: 103-111.
6. Ivorra MD, Paya M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989; 27: 243-275.
7. Jackson JE, Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1. Drugs 1981; 22: 211-245.
8. Jain, S.R Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with streptozotocin. Planta. Medica., 1: 43-47. (1968).
9. John A, Lott Turner K. (1975). Evaluation of trinder’s glucose oxidase method for measuring glucose in serum and urine. Clin. Chem. 21/12: 1754-1760.
10. Latha M, Pari L. Antihyperglycaemic effect of Cassia auriculata in experimental diabetes and its effects on key metabolic enzymes involved in carbohydrate metabolism. Clin Exp Pharmacol Physiol 2003b; 30: 38-43.
11. Latha M, Pari L. Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with streptozotocin. Mol Cell Biochem 2003a; 243: 23-28.
12. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. (1998). Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 47: 224-229.
13. Murugan P. Effect of cassia auriculata l on erythrocyte membrane bound enzymes andantioxidant status in experimental diabetes. International Journal of Recent Advances in Multidisciplinary Research. Vol. 02, Issue 12, pp.5760-5764, December, 2015c.
14. Murugan P. Effect of Cassia auriculata L on plasma antioxidants in streptozotocinnicotinamide induced experimental diabetes. International Journal of Information Research and Review. 2015b; Vol. 02, Issue, 05, pp.6930-6934.
15. Murugan P. Preventive effects of Cassia auriculata on brain lipid peroxidation streptozotocin diabetic rats. International Journal of Information Research and Review . 2015a ; Vol. 02, Issue, 05, pp.6924-6929.
16. Murugan P. Taner’s Cassia (Cassia auriculata L) extract prevents hemoglobin glycation tail tendon collagen properties in experimental diabetic rats. Journal of cell and tissue research. 2010; 10 (1): 2109-2114.
17. Pari L, Murugan P. Influence of Cassia auriculata flowers on Insulin Receptors in Streptozotocin Induced Diabetic Rats: Studies on Insulin Binding to Erythrocytes. African Journal of Biochemistry Research. 2007; 1 (7): 148-155.
18. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Diabetologia 1980; 18: 413-416.
19. Shrotri DS, Aiman R. (1960). The relationship of the post-absorptive state to the hypoglyceamic action. Ind J Med Res. 48: 162 – 168, 1960.
20. Spinas GA. The dual role of nitric oxide in isletscells. News Physiol Sci 1999; 14: 49-54.
21. Venkateswaran S, Pari L. Effect of Coccinia indica on blood glucose, insulin and hepatic key enzymes in experimental diabetes. Pharm Biol 2002; 40: 165-170.
22. WHO (World Health Organization). Expert Committee on diabetes mellitus, Second Report of the WHO Expert Committee on Diabetes mellitus. Technical Report Series. Geneva 1980; 646: 66.
23. WHO (World Health Organization). The expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003: 26; S5-S20.
24. WHO (World Health Organization). (1980). The expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 26; S5-S20.